HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Edward B Reilly Selected Research
Edward B Reilly Research Topics
Disease
18
Neoplasms (Cancer)
05/2024 - 05/2015
9
Glioblastoma (Glioblastoma Multiforme)
05/2024 - 05/2015
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 02/2017
2
Malignant Mesothelioma
10/2020 - 10/2020
2
Fatigue
01/2018 - 06/2015
2
Anemia
07/2008 - 10/2007
1
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2023
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2023
1
Hematologic Neoplasms (Hematological Malignancy)
01/2023
1
Toxic Optic Neuropathy
07/2022
1
Breast Neoplasms (Breast Cancer)
06/2021
1
Disease Progression
01/2021
1
Mesothelioma
10/2020
1
Oncogene Addiction
02/2016
1
Vomiting
06/2015
1
Nausea
06/2015
1
Dermatitis
06/2015
1
Squamous Cell Carcinoma of Head and Neck
05/2015
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2015
Drug/Important Bio-Agent (IBA)
13
Immunoconjugates (Immunoconjugate)
IBA
05/2024 - 01/2016
7
depatuxizumab mafodotin
IBA
05/2024 - 01/2018
6
depatuxizumab
IBA
07/2022 - 05/2015
5
ErbB Receptors (EGF Receptor)
IBA
01/2023 - 01/2018
4
epidermal growth factor receptor VIII
IBA
04/2021 - 05/2015
4
Epitopes
IBA
10/2020 - 05/2015
3
Antigens
IBA
01/2023 - 01/2021
3
ABT-414
IBA
07/2022 - 01/2016
3
Monoclonal Antibodies
IBA
01/2018 - 05/2015
2
Proteins (Proteins, Gene)
FDA Link
01/2023 - 06/2015
2
auristatin
IBA
06/2021 - 10/2020
2
Temozolomide (Temodar)
FDA Link
Generic
04/2021 - 01/2016
2
telisotuzumab vedotin
IBA
11/2018 - 02/2017
2
Cytotoxins (Cytolysins)
IBA
01/2018 - 02/2017
2
Erythropoietin Receptors (Erythropoietin Receptor)
IBA
07/2008 - 10/2007
1
HLA Antigens (Human Leukocyte Antigens)
IBA
01/2023
1
Survivin
IBA
01/2023
1
Peptides (Polypeptides)
IBA
01/2023
1
HLA-A Antigens (HLA-A)
IBA
01/2023
1
Estradiol (Delestrogen)
FDA Link
Generic
06/2021
1
DNA (Deoxyribonucleic Acid)
IBA
06/2021
1
Poly(ADP-ribose) Polymerase Inhibitors
IBA
06/2021
1
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
06/2021
1
Prolactin Receptors (Prolactin Receptor)
IBA
06/2021
1
Biomarkers (Surrogate Marker)
IBA
04/2021
1
monomethylauristatin F
IBA
01/2018
1
monomethyl auristatin E
IBA
01/2018
1
Cisplatin (Platino)
FDA Link
Generic
01/2017
1
monoclonal antibody 806
IBA
05/2015
1
Cetuximab (Erbitux)
FDA Link
05/2015
1
Erythropoietin
FDA Link
10/2007
Therapy/Procedure
5
Therapeutics
05/2024 - 05/2015
1
Immunotherapy
01/2023
1
Aftercare (After-Treatment)
04/2021
1
Drug Therapy (Chemotherapy)
02/2017